Jilong Zhang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.
Journal: Clinical and experimental medicine
Published: January 03, 2026
Vitamin C enhances cisplatin sensitivity in bladder cancer via 5hmC-mediated epigenetic modulation of ATF4.
Journal: Clinical epigenetics
Published: September 24, 2025
Single-cell RNA sequencing identifies potential critical prognostic biomarkers in bladder carcinoma.
Single-cell RNA sequencing identifies potential critical prognostic biomarkers in bladder carcinoma.
Journal: Scientific reports
Published: June 09, 2025
LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.
Journal: Clinical and experimental medicine
Published: May 21, 2025
Patients with multiple mpMRI region of interests: should we omit targeted biopsies of secondary lesions?
Journal: Abdominal radiology (New York)
Published: November 28, 2024
Clinical, Prognosis, and Treatment Effect Features Analysis of Metachronous and Synchronous UTUC and BUC.
Journal: Clinical genitourinary cancer
Published: June 20, 2024
A Novel Urine DNA Predictor for Noninvasive Early Diagnosis and Monitoring Minimal Residual Disease of Upper Tract Urothelial Carcinoma.
Journal: Cancer medicine
Published: April 10, 2024
Minimal-invasive ileal ureter replacement for the management of multiple ureteral polyps: the initial experience.
Journal: International urology and nephrology
Published: August 17, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026